Cigna Investments’s B2Gold BTG Stock Holding History

Cigna Investments’s Portfolio BTG Stock Details BTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,749	Closed	-$54K	–	658
2021 Q3	$54K	Hold	15,749	–	–	﹤0.01%	734
2021 Q2	$66K	Hold	15,749	–	–	﹤0.01%	745
2021 Q1	$68K	Hold	15,749	–	–	﹤0.01%	763
2020 Q4	$88K	Buy	15,749 +864	+6%	+$5.28K	0.01%	724
2020 Q3	$96K	Hold	14,885	–	–	0.01%	623
2020 Q2	$85K	Buy	+14,885	New	+$74.6K	0.01%	745

Other funds holding BTG

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cigna Investments's BTG Position: Q4 2021 in Review

Cigna Investments sold out of B2Gold (BTG) in Q4 2021, closing a stake of 15,749 shares — an estimated $54K sold.

Cigna Investments first reported a position in BTG in Q2 2020 and held it in 6 quarters. The position peaked at $96K in Q3 2020. 234 funds tracked by Wall St. Rank hold BTG as of Q4 2021.

Cigna Investments reported no remaining B2Gold position as of Q4 2021 after selling out during the quarter.
Cigna Investments sold 15,749 B2Gold shares in Q4 2021, an estimated $54K.
Cigna Investments first reported a position in B2Gold in Q2 2020 and held it in 6 quarters.
Cigna Investments's B2Gold position peaked at $96K in Q3 2020.
234 funds tracked by Wall St. Rank held B2Gold as of Q4 2021.

Based on Cigna Investments's 13F filing for Q4 2021, filed 14 Feb 2022.